Condition

Relapsing-remitting Multiple Sclerosis (RRMS) clinical trials and research

• 6Clinical trials
• 6Countries

Newest Relapsing-remitting Multiple Sclerosis (RRMS) clinical trials

All recruiting trials (6)

• Rocbrutinib in PRL-Positive Relapsing-Remitting MS

  This study tests whether Rocbrutinib can help people with relapsing-remitting MS who have paramagnetic rim lesions, compared to dimethyl fumarate.

  Recruiting Phase 2 Guangzhou Lupeng Pharmaceutical Company LTD. · Beijing, Beijing Municipality · NCT07776743

• BCD-281 versus ocrelizumab for relapsing-remitting multiple sclerosis

  This study tests whether BCD-281 works as well and is as safe as ocrelizumab for adults 18–55 with relapsing‑remitting multiple sclerosis.

  Recruiting Phase 3 Biocad · Nizhny Novgorod · NCT07321093

• Indole-3-propionic acid supplementation for relapsing-remitting MS

  This trial tests whether taking oral indole-3-propionic acid (a gut-derived supplement) can help protect people with relapsing‑remitting MS from disease activity, nerve damage, and related metabolic problems.

  Recruiting Glostrup University Hospital, Copenhagen · Glostrup Municipality · NCT07318129

• Anti-CD20 maintenance vs. de-escalation in relapsing-remitting MS

  This trial tests whether continuing anti-CD20 therapy at standard maintenance is as good as a de-escalated approach in people with relapsing-remitting MS who have been on anti-CD20 treatment for at least 3 years.

  Recruiting Phase 3 University Hospital, Montpellier · Montpellier · NCT07189325

• Using eye movement biomarkers to track disease changes in active RRMS patients

  This study is testing if tracking eye movements can help doctors see how well a new treatment works for people with active Relapsing Remitting Multiple Sclerosis.

  Recruiting at 14 sites Phase 4 Novartis · Calgary, Alberta and 13 other locations · NCT06733922

• Imaging axonal damage and repair in multiple sclerosis

  This study is testing new MRI techniques to see how axons are damaged and repaired in people with multiple sclerosis over two years.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT05177523

Related topics

Quick answers

How many Relapsing-remitting Multiple Sclerosis (RRMS) clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in Denmark (1 trial), China (1 trial), Canada (1 trial), France (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →